Thrombin Generation Measured Ex Vivo Following Microvasculor Injury Is Increased in SLE Patients with Antiphospholipid-protein Antibodies
- 1 June 1997
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 78 (04) , 1173-1177
- https://doi.org/10.1055/s-0038-1657710
Abstract
Antiphospholipid-protein antibodies (APA) include lupus-type anticoagulant (LA) and antibodies recognizing complexes of anionic phospholipids (e.g. cardiolipin) and proteins (e.g. prothrombin and (β2-glycoprotein I). The presence of APA is associated with an increased risk of both arterial and venous thrombosis. However, the pathogenic mechanism leading to thrombosis in patients with APA remains unclear. We studied 32 patients with systemic lupus erythematosus (SLE) who were divided into two groups depending on the presence (n = 19) or absence (n = 13) of APA. Healthy volunteers (n = 12) matched by age and sex served as controls. In all subjects LA and IgG class anticardiolipin antibodies (ACA) were determined. Thrombin generation was monitored ex vivo measuring fibrinopeptide A (FPA) and prothrombin fragment F1 + 2 (F1 + 2) in blood emerging from a skin microvasculature injury, collected at 30 second intervals. In subjects with antiphospholipid antibodies mean FPA and F1 + 2 concentrations were signiF1cantly higher at most blood sampling times than in controls. In some SLE patients with APA the process of thrombin generation was clearly disturbed and very high concentrations of F1brinopeptide A were detected already in the F1rst samples collected. Two minutes after skin incision SLE patients without APA produced slightly more FPA, but not F1 + 2, as compared to healthy subjects. Mathematical model applied to analyze the thrombin generation kinetics revealed that APA patients generated signiF1cantly greater amounts of thrombin than healthy controls (p = 0.02 for either marker). In contrast, in the same patients generation of thrombin in recalciF1ed plasma in vitro was delayed pointing to the role of endothelium in the phenomenon studied. In summary, these data show for the F1rst time that in SLE patients with antiphospholipid-protein antibodies thrombin generation after small blood vessel injury is markedly increased. Enhanced thrombin generation might explain thrombotic tendency observed in these patients.Keywords
This publication has 13 references indexed in Scilit:
- Antiphospholipid Antibodies Activate Vascular Endothelial CellsLupus, 1996
- Vasculopathy of the Antiphospholipid Syndromes Revisited: Thrombosis is the Culprit and Vasculitis the ConsortLupus, 1996
- The Antiphospholipid SyndromeLupus, 1996
- Inhibition of Thrombin Generation by Aspirin Is Blunted in HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Anticardiolipin antibodies in systemic lupus erythematosus: Clinical and laboratory correlationsThe American Journal of Medicine, 1995
- Antiphospholipid-protein antibodies: Laboratory detection and clinical relevanceThrombosis Research, 1995
- Criteria for the Diagnosis of Lupus Anticoagulants: An UpdateThrombosis and Haemostasis, 1995
- Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.Annals of the Rheumatic Diseases, 1988
- Generation of the proteolytic activity bound with α2-macroglobulin during plasma clottingClinica Chimica Acta; International Journal of Clinical Chemistry, 1970
- A Simple Method of Studying the Generation of Thrombin in Recalcified Plasma: Application in the Investigation of HaemophiliaJournal of Clinical Pathology, 1953